Elviteg/Cob/Emtri/Tenof Alafen
Brand name: Genvoya
Rank #80 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$236.5M
Total Cost
56,626
Total Claims
$236.5M
Total Cost
1,682
Prescribers
$4,177
Cost per Claim
2,232
Beneficiaries
59,201
30-Day Fills
$141K
Avg Cost/Provider
34
Avg Claims/Provider
Share of Medicare Part D Spending
0.09%
of total Medicare Part D spending
$236.5M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $236.5M total
🔎 Data Overview
At $4,177 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $140,626 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $105,974 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Elviteg/Cob/Emtri/Tenof Alafen
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Sharon Reiley | Nurse Practitioner | Jacksonville, FL | 525 | $2.0M |
| 2 | Joseph Horvath | Infectious Disease | Columbia, SC | 326 | $1.4M |
| 3 | Joseph Gathe | Infectious Disease | Houston, TX | 265 | $1.1M |
| 4 | Marc Johnson | Internal Medicine | Charlotte, NC | 267 | $1.1M |
| 5 | Margarita Lamothe | Infectious Disease | Memphis, TN | 259 | $1.1M |
| 6 | Steven Norris | Infectious Disease | Indianapolis, IN | 234 | $1.0M |
| 7 | Michael Dorcik | Obstetrics & Gynecology | Biloxi, MS | 239 | $987K |
| 8 | Leia Hoang | Pharmacist | San Diego, CA | 100 | $956K |
| 9 | Karen Maher | Nurse Practitioner | Rockford, IL | 237 | $954K |
| 10 | Jill Frickenhaus | Nurse Practitioner | New York, NY | 225 | $914K |
| 11 | Cheryl Mcdonald | Infectious Disease | Fort Worth, TX | 219 | $909K |
| 12 | John Quale | Internal Medicine | Brooklyn, NY | 214 | $857K |
| 13 | Leonard Berkowitz | Infectious Disease | Brooklyn, NY | 202 | $835K |
| 14 | Luis Cisneros | Infectious Disease | San Antonio, TX | 190 | $791K |
| 15 | Catherine Colquitt | Infectious Disease | Fort Worth, TX | 183 | $785K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 77 | Abemaciclib (Verzenio) | $242.2M | 16,125 |
| 78 | Abacavir/Dolutegravir/Lamivudi (Triumeq) | $238.1M | 61,147 |
| 79 | Riociguat (Adempas) | $236.6M | 17,620 |
| 80 | Elviteg/Cob/Emtri/Tenof Alafen (Genvoya) | $236.5M | 56,626 |
| 81 | Emtricitabine/Tenofov Alafenam (Descovy) | $222.4M | 94,580 |
| 82 | Immun Glob G(Igg)/Gly/Iga Ov50 (Gammagard Liquid) | $222.1M | 22,768 |
| 83 | Immun Glob G(Igg)/Pro/Iga 0-50 (Hizentra) | $222.0M | 21,722 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology